Cargando…

Cytomegalovirus Glycoprotein Polymorphisms and Increasing Viral Load in Non-Transplant Patients with Hematological Malignancies Undergoing Chemotherapy: A Prospective Observational Study

INTRODUCTION: Cytomegalovirus (CMV) predisposes to several clinical complications and is a major cause of morbidity and mortality in immunocompromised patients, including patients with hematological malignancies (HM). The present study was carried out to determine the distribution of CMV glycoprotei...

Descripción completa

Detalles Bibliográficos
Autores principales: Handous, Imene, Hannachi, Naila, Achour, Bechir, Marzouk, Manel, Hazgui, Olfa, Khelif, Abderrahim, Boukadida, Jalel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322362/
https://www.ncbi.nlm.nih.gov/pubmed/34148225
http://dx.doi.org/10.1007/s40121-021-00457-z
_version_ 1783731033973194752
author Handous, Imene
Hannachi, Naila
Achour, Bechir
Marzouk, Manel
Hazgui, Olfa
Khelif, Abderrahim
Boukadida, Jalel
author_facet Handous, Imene
Hannachi, Naila
Achour, Bechir
Marzouk, Manel
Hazgui, Olfa
Khelif, Abderrahim
Boukadida, Jalel
author_sort Handous, Imene
collection PubMed
description INTRODUCTION: Cytomegalovirus (CMV) predisposes to several clinical complications and is a major cause of morbidity and mortality in immunocompromised patients, including patients with hematological malignancies (HM). The present study was carried out to determine the distribution of CMV glycoprotein B, N, and O (gB, gN, and gO) genotypes and their potential effect on its viral load and on clinical outcomes in a cohort of Tunisian non-hematopoietic stem cell transplant (HSCT) patients with HM undergoing chemotherapy. METHODS: CMV viral load was evaluated by real-time quantitative PCR. The gB, gN, and gO genotypes of the CMV strains were analyzed by multiplex nested PCR and sequencing. RESULTS: This prospective study involved 60 clinical isolates obtained from 60 non-HSCT patients with HM undergoing chemotherapy. Mixed CMV gB, gN, and gO genotypes were the predominant glycoprotein genotypes in 31%, 41.4%, and 46.4% of patients, respectively. Mixed gB genotypes were associated with higher initial levels of CMV load (p = 0.001), increased rate of fever (0.025), and co-infection with other herpesviruses (HHVs) (p = 0.024) more frequently than in single gB genotype. Mixed gN genotypes were more associated with severe lymphopenia (ALC < 500/µL) (p = 0.01) and increased risk of death (p = 0.042) than single gN genotype. Single gO2b genotype had also a more unfavorable outcome (p = 0.009) than the other single gO genotype. Mixed gO genotypes were associated with female gender (p = 0.015), acute leukemia disease (p = 0.036), initial high level of CMV viral load (at least 1000 copies/mL) (p = 0.029), skin rash (p = 0.01) more frequently than in single gO genotype. The gO1a/gN3b linkage was associated with an increased initial viral load (p = 0.012). CONCLUSION: Infection with mixed CMV genotypes was common and multiple gB, gN, and gO genotypes were associated with clinical manifestation and higher viral load. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40121-021-00457-z.
format Online
Article
Text
id pubmed-8322362
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-83223622021-08-19 Cytomegalovirus Glycoprotein Polymorphisms and Increasing Viral Load in Non-Transplant Patients with Hematological Malignancies Undergoing Chemotherapy: A Prospective Observational Study Handous, Imene Hannachi, Naila Achour, Bechir Marzouk, Manel Hazgui, Olfa Khelif, Abderrahim Boukadida, Jalel Infect Dis Ther Original Research INTRODUCTION: Cytomegalovirus (CMV) predisposes to several clinical complications and is a major cause of morbidity and mortality in immunocompromised patients, including patients with hematological malignancies (HM). The present study was carried out to determine the distribution of CMV glycoprotein B, N, and O (gB, gN, and gO) genotypes and their potential effect on its viral load and on clinical outcomes in a cohort of Tunisian non-hematopoietic stem cell transplant (HSCT) patients with HM undergoing chemotherapy. METHODS: CMV viral load was evaluated by real-time quantitative PCR. The gB, gN, and gO genotypes of the CMV strains were analyzed by multiplex nested PCR and sequencing. RESULTS: This prospective study involved 60 clinical isolates obtained from 60 non-HSCT patients with HM undergoing chemotherapy. Mixed CMV gB, gN, and gO genotypes were the predominant glycoprotein genotypes in 31%, 41.4%, and 46.4% of patients, respectively. Mixed gB genotypes were associated with higher initial levels of CMV load (p = 0.001), increased rate of fever (0.025), and co-infection with other herpesviruses (HHVs) (p = 0.024) more frequently than in single gB genotype. Mixed gN genotypes were more associated with severe lymphopenia (ALC < 500/µL) (p = 0.01) and increased risk of death (p = 0.042) than single gN genotype. Single gO2b genotype had also a more unfavorable outcome (p = 0.009) than the other single gO genotype. Mixed gO genotypes were associated with female gender (p = 0.015), acute leukemia disease (p = 0.036), initial high level of CMV viral load (at least 1000 copies/mL) (p = 0.029), skin rash (p = 0.01) more frequently than in single gO genotype. The gO1a/gN3b linkage was associated with an increased initial viral load (p = 0.012). CONCLUSION: Infection with mixed CMV genotypes was common and multiple gB, gN, and gO genotypes were associated with clinical manifestation and higher viral load. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40121-021-00457-z. Springer Healthcare 2021-06-19 2021-09 /pmc/articles/PMC8322362/ /pubmed/34148225 http://dx.doi.org/10.1007/s40121-021-00457-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Handous, Imene
Hannachi, Naila
Achour, Bechir
Marzouk, Manel
Hazgui, Olfa
Khelif, Abderrahim
Boukadida, Jalel
Cytomegalovirus Glycoprotein Polymorphisms and Increasing Viral Load in Non-Transplant Patients with Hematological Malignancies Undergoing Chemotherapy: A Prospective Observational Study
title Cytomegalovirus Glycoprotein Polymorphisms and Increasing Viral Load in Non-Transplant Patients with Hematological Malignancies Undergoing Chemotherapy: A Prospective Observational Study
title_full Cytomegalovirus Glycoprotein Polymorphisms and Increasing Viral Load in Non-Transplant Patients with Hematological Malignancies Undergoing Chemotherapy: A Prospective Observational Study
title_fullStr Cytomegalovirus Glycoprotein Polymorphisms and Increasing Viral Load in Non-Transplant Patients with Hematological Malignancies Undergoing Chemotherapy: A Prospective Observational Study
title_full_unstemmed Cytomegalovirus Glycoprotein Polymorphisms and Increasing Viral Load in Non-Transplant Patients with Hematological Malignancies Undergoing Chemotherapy: A Prospective Observational Study
title_short Cytomegalovirus Glycoprotein Polymorphisms and Increasing Viral Load in Non-Transplant Patients with Hematological Malignancies Undergoing Chemotherapy: A Prospective Observational Study
title_sort cytomegalovirus glycoprotein polymorphisms and increasing viral load in non-transplant patients with hematological malignancies undergoing chemotherapy: a prospective observational study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322362/
https://www.ncbi.nlm.nih.gov/pubmed/34148225
http://dx.doi.org/10.1007/s40121-021-00457-z
work_keys_str_mv AT handousimene cytomegalovirusglycoproteinpolymorphismsandincreasingviralloadinnontransplantpatientswithhematologicalmalignanciesundergoingchemotherapyaprospectiveobservationalstudy
AT hannachinaila cytomegalovirusglycoproteinpolymorphismsandincreasingviralloadinnontransplantpatientswithhematologicalmalignanciesundergoingchemotherapyaprospectiveobservationalstudy
AT achourbechir cytomegalovirusglycoproteinpolymorphismsandincreasingviralloadinnontransplantpatientswithhematologicalmalignanciesundergoingchemotherapyaprospectiveobservationalstudy
AT marzoukmanel cytomegalovirusglycoproteinpolymorphismsandincreasingviralloadinnontransplantpatientswithhematologicalmalignanciesundergoingchemotherapyaprospectiveobservationalstudy
AT hazguiolfa cytomegalovirusglycoproteinpolymorphismsandincreasingviralloadinnontransplantpatientswithhematologicalmalignanciesundergoingchemotherapyaprospectiveobservationalstudy
AT khelifabderrahim cytomegalovirusglycoproteinpolymorphismsandincreasingviralloadinnontransplantpatientswithhematologicalmalignanciesundergoingchemotherapyaprospectiveobservationalstudy
AT boukadidajalel cytomegalovirusglycoproteinpolymorphismsandincreasingviralloadinnontransplantpatientswithhematologicalmalignanciesundergoingchemotherapyaprospectiveobservationalstudy